BALA CYNWYD, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
VIZIO Holding Corp. (NYSE - VZIO)
Under the terms of the agreement, VIZIO will be acquired by Walmart Inc. for $11.50 per share in cash in a deal valued at approximately $2.3 billion. The investigation concerns whether the VIZIO Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Walmart is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/vizio-holding-corp-nyse-vzio/.
HireRight Holdings Corporation (NYSE – HRT)
Under the terms of the Merger Agreement, HireRight will be acquired by investment funds affiliated with General Atlantic, L.P. (“General Atlantic”) and Stone Point Capital LLC (“Stone Point” and together with General Atlantic, the “Sponsors”). The Sponsors are currently the beneficial owners of approximately 75% of the Company’s outstanding shares of common stock. The Sponsors will acquire all of the outstanding shares they do not already own for $14.35 per share in cash, which implies a total enterprise value of approximately $1.65 billion. The investigation concerns whether the HireRight Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Sponsors are paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/hireright-holdings-corporation-nyse-hrt/.
Kinnate Biopharma Inc. (Nasdaq – KNTE)
Under the terms of the agreement, Kinnate will be acquired by XOMA Corporation (“XOMA”) (Nasdaq - XOMA). Kinnate shareholders will receive (i) a base cash price of $2.3352 per share (the Base Price) and (ii) an additional cash amount of not more than $0.2527 per share (together with the Base Price, the Cash Amount) at the closing of the merger plus a non-transferable contingent value right (CVR), representing the right to receive 85% of the net proceeds from any out license or sale of the Kinnate programs effected within one year of closing of the merger or 100% of the net proceeds from any out license or sale executed prior to the closing. The investigation concerns whether the Kinnate Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether XOMA is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/kinnate-biopharma-inc-nasdaq-knte/.
California BanCorp (Nasdaq – CALB)
Under the terms of the agreement, California Bancorp will merge with Southern California Bancorp (Nasdaq - BCAL). The companies will combine in an all-stock merger valued at approximately $233.6 million, or $26.54 per share of California BanCorp, based on the closing price of Southern California Bancorp on January 29, 2024. Specifically, each outstanding share of California BanCorp common stock will be exchanged for the right to receive 1.590 shares of Southern California Bancorp common stock. As a result of the transaction, Southern California Bancorp shareholders will own approximately 57.1% of the outstanding shares of the combined company and California BanCorp shareholders will own approximately 42.9% of the outstanding shares of the combined company. The investigation concerns whether the California BanCorp Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to California BanCorp shareholders in the combined company.
Additional information can be found at https://www.brodskysmith.com/cases/california-bancorp-nasdaq-calb/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
